Metabolism


Serine/threonine kinase AMPK upregulates glucose uptake by promoting the expression and function of glucose transporters. AMPK is activated by increased AMP/ATP ratio, resulting from cellular and environmental stress, e.g. low glucose, heat shock, hypoxia and ischemia. AMPK activation positively modulates signaling transductions that refill ATP levels. Moreover, it also stimulates catabolic processes such as fatty acid oxidation and glycolysis through inhibition of ACC and activation of PFK2. AMPK negatively regulates various proteins which are important to ATP-consuming mechanisms, e.g. mTORC2, glycogen synthase, SREBP-1, and TSC2, causing the downregulation/inhibition of gluconeogenesis and glycogen, lipid and protein synthesis.
-
B7701 JZL 195Summary: Dual inhibitor of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL) -
B7714 3-Cyano-7-ethoxycoumarinSummary: Fluorescent P450 substrate -
B5162 T 0156 hydrochlorideSummary: inhibitor of phosphodiesterase type 5 (PDE5) -
B5354 CGP 3466B maleateTarget: GAPDHSummary: GAPDH inhibitor -
C6859 L-Ornithine L-aspartate -
C6975 Phenylglyoxal hydrate -
C7022 CetilistatSummary: an inhibitor of pancreatic lipase -
C7063 2,6-Dihydroxyanthraquinone -
C7113 3-Methylpyrazole -
C7156 10-Undecen-1-ol

